Cite

HARVARD Citation

    Gutkind, S. et al. (2020). Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs. Clinical infectious diseases. pp. 1397-1405. [Online]. 
  
Back to record